Page 37 - Michael Erman News Today

By Julie Steenhuysen and Michael Erman (Reuters) - An experimental mRNA cancer vaccine developed by Moderna Inc and Merck & Co cut the risk of ...

WASHINGTON (Reuters) - The U.S. government aims to publish the final guidance for its Medicare drug price negotiation program in early July and is currently talking to companies about its contents, a top health official said on Wednesday. | 06:20pm

Executives from more than 300 biotech and pharmaceutical industry companies, including Pfizer and Biogen, signed an open letter on Monday calling for reversal of a federal judges decision to suspend sales of the abortion pill mifepristone.

(Reuters) -Over 300 biotech and pharmaceutical industry executives, including Pfizer Inc CEO Albert Bourla, signed an open letter on Monday calling for reversal of a federal judge's decision to suspend sales of the abortion pill mifepristone. | 12:19pm

Over 300 biotech and pharmaceutical industry executives, including Pfizer Inc CEO Albert Bourla, signed an open letter on Monday calling for reversal of a federal judge's decision to suspend sales of the abortion pill mifepristone.

Over 300 biotech and pharmaceutical industry executives, including Pfizer Inc CEO Albert Bourla, signed an open letter on Monday seeking the reversal of a federal judges decision to suspend sales of... | April 10, 2023

By Michael Erman and Ahmed Aboulenein

The decision puts the entire industry at risk, the letter says, and sets a precedent for undermining the agency's authority to approve drugs, adding regulatory uncertainty that they warned would disincentivize investment in new treatments.

By Michael Erman and Ahmed Aboulenein (Reuters) -Executives from more than 300 biotech and pharmaceutical industry companies, including Pfizer Inc and ...

Johnson & Johnson said it will discontinue the late-stage study of its experimental RSV adult vaccine, weeks after rivals Pfizer and GSK gained a lead in the race for the first vaccine against the virus.